£2.3M
The medical device maker has raised fresh capital from backers including Crimson International Investment to support its global growth plans.
"We are delighted to secure further funding, as well as another strategic investor and partner to take our pioneering Parkinson’s monitoring device into new markets. NICE’s positive evaluation and recommendation, which supports NHS use of PDMonitor, was a big endorsement for our business and technology."
